Skip to main content
Premium Trial:

Request an Annual Quote

Clinical Data to Help Quintiles Study Long-QT

NEW YORK (GenomeWeb News) — Clinical Data today said it will use its diagnostic technologies to help Quintiles Transnational study drug-induced QT prolongation, the company said today.
Clinical Data said it will offer several services that focus on the potential genetic causes of QT prolongation and to help Quintiles with regulatory guidelines.
Long-QT is contributes to delays in drug development and drug withdrawals.
Financial terms of the deal were not disclosed.

The Scan

Review of Approval Process

Stat News reports the Department for Health and Human Services' Office of the Inspector General is to investigate FDA's approval of Biogen's Alzheimer's disease drug.

Not Quite Right

A new analysis has found hundreds of studies with incorrect nucleotide sequences reported in their methods, according to Nature News.

CRISPR and mRNA Together

Time magazine reports on the use of mRNA to deliver CRISPR machinery.

Nature Papers Present Smartphone Platform for DNA Diagnosis of Malaria, Mouse Lines for Epigenomic Editing

In Nature this week: a low-cost tool to detect infectious diseases like malaria, and more.